Literature DB >> 29292602

OPTN/SRTR 2016 Annual Data Report: Lung.

M Valapour1,2, C J Lehr2, M A Skeans1, J M Smith1,3, R Carrico4,5, K Uccellini4,5, R Lehman4,5, A Robinson4,5, A K Israni1,6,7, J J Snyder1,6, B L Kasiske1,7.   

Abstract

In 2016, 2692 candidates aged 12 years or older were added to the lung transplant waiting list; 2345 transplants were performed, the largest number of any prior year. The median waiting time for listed candidates in 2016 was 2.5 months, and waiting times were shortest for group D candidates. The transplant rate increased to 191.9 transplants per 100 waitlist years in 2016, with a slight decrease in waitlist mortality to 15.1 deaths per 100 waitlist years. Short-term survival continued to improve, with a 6-month death rate of 6.6% and a 1-year death rate of 10.8% among recipients in 2015 compared with 8.0% and 13.3%, respectively, among recipients in 2014. Long-term survival rates remained unchanged; 55.6% of recipients were alive at 5 years. In 2016, 23 new candidates aged 0-11 years were added to the waiting list and 16 lung transplants were performed. Incidence of posttransplant mortality for lung transplant recipients aged 0-11 years who underwent transplant in 2014-2015 was 13.8% at 6 months and 19.6% at 1 year. Changes in waitlist and transplant demographic features continued to evolve following implementation of the revised lung allocation score in 2015. Some early trends that may be attributable to the revised LAS are shorter waiting times, stabilization of the number of group D candidates listed for transplant, and convergence of LAS with lower prevalence of extremely high scores. .

Entities:  

Keywords:  zzm321990LASzzm321990; End-stage lung disease; lung allocation score; lung transplant; organ allocation; revised lung allocation score; transplant outcomes

Mesh:

Year:  2018        PMID: 29292602     DOI: 10.1111/ajt.14562

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  34 in total

1.  Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States.

Authors:  Laneshia K Tague; Chad A Witt; Derek E Byers; Roger D Yusen; Patrick R Aguilar; Hrishikesh S Kulkarni; Karen Bennett Bain; Keith A Fester; Varun Puri; Daniel Kreisel; Thalachallour Mohanakumar; Elbert P Trulock; Ramsey R Hachem
Journal:  Ann Am Thorac Soc       Date:  2019-07

Review 2.  Bioengineering approaches to organ preservation ex vivo.

Authors:  Meghan Pinezich; Gordana Vunjak-Novakovic
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-19

3.  Rare Lung Disease Research: National Heart, Lung, and Blood Institute's Commitment to Partnership and Progress.

Authors:  Louis J Vuga; Neil R Aggarwal; Lora A Reineck; Roya Kalantari; Koyeli Banerjee; James Kiley
Journal:  Chest       Date:  2019-05-20       Impact factor: 9.410

4.  Which Shall I Choose? Lung Transplantation Listing Preference for Individuals with Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Kathleen J Ramos; Michael O Harhay; Michael S Mulligan
Journal:  Ann Am Thorac Soc       Date:  2019-02

5.  Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study.

Authors:  Michaela R Anderson; Ashley Tabah; Arindam RoyChoudhury; David J Lederer
Journal:  Ann Am Thorac Soc       Date:  2019-02

6.  Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction.

Authors:  Beñat Mallavia; Fengchun Liu; Emma Lefrançais; Simon J Cleary; Nicholas Kwaan; Jennifer J Tian; Mélia Magnen; David M Sayah; Allison Soong; Joy Chen; Rajan Saggar; Michael Y Shino; David J Ross; Ariss Derhovanessian; Joseph P Lynch; Abbas Ardehali; S Sam Weigt; John A Belperio; Steven R Hays; Jeffrey A Golden; Lorriana E Leard; Rupal J Shah; Mary Ellen Kleinhenz; Aida Venado; Jasleen Kukreja; Jonathan P Singer; Mark R Looney
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

Review 7.  Detection, classification, and management of rejection after lung transplantation.

Authors:  Amit D Parulekar; Christina C Kao
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

8.  Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation.

Authors:  Yaron D Barac; Mike S Mulvihill; Oliver Jawitz; Jacob Klapper; John Haney; Mani Daneshmand; Basil Nasir; Dongfeng Chen; Carmelo A Milano; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2020-04-03       Impact factor: 4.330

Review 9.  The ex vivo human lung: research value for translational science.

Authors:  James T Ross; Nicolas Nesseler; Jae-Woo Lee; Lorraine B Ware; Michael A Matthay
Journal:  JCI Insight       Date:  2019-06-06

10.  Frailty phenotypes and mortality after lung transplantation: A prospective cohort study.

Authors:  Jonathan P Singer; Joshua M Diamond; Michaela R Anderson; Patricia P Katz; Ken Covinsky; Michelle Oyster; Tatiana Blue; Allison Soong; Laurel Kalman; Pavan Shrestha; Selim M Arcasoy; John R Greenland; Lori Shah; Jasleen Kukreja; Nancy P Blumenthal; Imaani Easthausen; Jeffrey A Golden; Amika McBurnie; Ed Cantu; Joshua Sonett; Steven Hays; Hilary Robbins; Kashif Raza; Matthew Bacchetta; Rupal J Shah; Frank D'Ovidio; Aida Venado; Jason D Christie; David J Lederer
Journal:  Am J Transplant       Date:  2018-05-14       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.